Evidence map›Paper›PMID 21751871›Full record

ArticleOmics : a journal of integrative biology2013

Metabolomics reveals differential levels of oral metabolites in HIV-infected patients: toward novel diagnostic targets.

Mahmoud A Ghannoum, Pranab K Mukherjee, Richard J Jurevic, Mauricio Retuerto, Robert E Brown, Masoumeh Sikaroodi, Jennifer Webster-Cyriaque, Patrick M Gillevet

Open access · greenAbstract read
In one paragraph

Article in Omics : a journal of integrative biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Metabolomics as a Tool to Investigate HIV/TB Co-Infection.Frontiers in molecular biosciences · 2021
    Review
  7. Salivary metabolite levels in perinatally HIV-infected youth with periodontal disease.Metabolomics : Official journal of the Metabolomic Society · 2020
    Observational
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Mahmoud A GhannoumCenter for Medical Mycology, Case Western Reserve University, Ohio 44106-5028, USA. Mahmoud.Ghannoum@case.edu
Pranab K Mukherjee
Richard J Jurevic
Mauricio Retuerto
Robert E Brown
Masoumeh Sikaroodi
Jennifer Webster-Cyriaque
Patrick M Gillevet
Case Western Reserve University · USGeorge Mason University · USUniversity of North Carolina at Chapel Hill · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024989 · NCRR · CASE WESTERN RESERVE UNIVERSITY · PI DAVIS, PAMELA B · 2007 to 2011
$53.7M
Proj. 4-The Genetic Variation of Innate Immune Genes w/Oral Manifestations of HIVP01DE019759 · NIDCR · CASE WESTERN RESERVE UNIVERSITY · PI ZIMMERMAN, PETER · 2009 to 2013
$9.0M
PHOSPHOLIPASES AND THE VIRULENCE OF C ALBICANSR01AI035097 · NIAID · LA BIOMED RES INST/ HARBOR UCLA MED CTR · PI GHANNOUM, MAHMOUD A · 1995 to 2009
$2.6M
Identification of early phase C. albicans biofilm proteinsR01DE017486 · NIDCR · CASE WESTERN RESERVE UNIVERSITY · PI GHANNOUM, MAHMOUD A · 2007 to 2011
$1.8M
Biology and Drug Resistance of Candida BiofilmsR01DE013932 · NIDCR · CASE WESTERN RESERVE UNIVERSITY · PI GHANNOUM, MAHMOUD A · 2002 to 2005
$1.4M
Defensin Gene Cluster Variation &Candida CarriageK23DE016110 · NIDCR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI JUREVIC, RICHARD J · 2005 to 2009
$629k
Role of extracellular matrix proteins in Candida biofilm formationR21AI074077 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI MUKHERJEE, PRANAB KUMAR · 2009 to 2010
$432k
NIAID NIH HHS 1R21AI074077-01A2NIAID NIH HHS R01 AI035097NIDCR NIH HHS 1K23-DE016110-01KNIDCR NIH HHS 1P01-DE019759-01NIDCR NIH HHS R01 DE017486-01A1NIDCR NIH HHS R01DE 13932-4
6 · The paper itself

Abstract

The objective of the current study was to characterize the profile of oral metabolites in HIV-infected patients using metabolomics. Oral wash samples were collected from 12 HIV-infected and 12 healthy individuals (matched for age, sex, and ethnicity), processed, and analyzed by metabolomics. We detected 198 identifiable and 85 nonidentifiable metabolites; 27 identifiable metabolites were differentially present (12 increased, 15 decreased) in HIV-infected patients. Elevated metabolites included p-cresol sulfate, nucleotides (e.g., allantoin), and amino acids (e.g., phenylalanine, tryptophan), whereas decreased oral metabolites included fucose, fumarate, and N-acetylglucosamine. Pathway network analysis revealed the largest multinode network in healthy versus HIV-infected patients to involve carbohydrate biosynthesis and degradation. HIV-infected patients on antiretroviral therapy (ART) showed the largest number (12) of statistically significant metabolite correlation differences compared with healthy controls. Interestingly, the oral phenlyalanine:tyrosine ratio increased in ART-naive HIV-infected patients (mean ± SEM = 2.58 ± 0.87) compared with healthy individuals (1.33 ± 0.10, p = 0.062) or ART-experienced patients (1.78 ± 0.30, p = 0.441). This is the first study to reveal differential levels of oral metabolites in HIV-infected patients compared withj healthy volunteers, and that oral phenlyalanine:tyrosine ratio may be a useful marker for noninvasive monitoring of the immune status during HIV infection.

Indexed as

MetabolomicsAdultAnti-HIV AgentsCase-Control StudiesChromatography, LiquidFemaleGas Chromatography-Mass SpectrometryHIV InfectionsHumansMaleMass SpectrometryMiddle AgedMouthPhenylalanineTyrosineAnti-HIV AgentsPhenylalanineTyrosine

Identifiers

PMID21751871
PMCPMC3545316
OpenAlexW1973453550

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.